Home » Newsletters » BioWorld Science

BioWorld Science

July 7, 2014

View Archived Issues

Novel GLP-1 agonist TTP-273 reduces glucose levels in type 2 diabetes patients

Manganese porphyrin antioxidant ameliorates experimental type 2 diabetes

Kyowa Hakko Kirin to start new phase II study of bardoxolone methyl

Amarantus announces toxicology data for MANF in retinitis pigmentosa

Jazz Pharmaceuticals gains rights to Defitelio in the Americas from Sigma-Tau

Synchroneuron's development of SNC-102 supported by Series B funding

Novel beta2-adrenoceptor agonists for the treatment of respiratory disorders

Voltage-gated calcium channels, potential targets for chronic pain

AVEO Pharmaceuticals discloses novel anti-FGFR-2 MAbs

AIMM Therapeutics to receive milestone payment

First patients dosed in a phase II trial of the novel antibiotic SMT-19969

Dual calcitonin and amylin receptor agonists show potential for obesity, diabetes and osteoarthritis

Dermira licenses Cimzia for psoriasis

Novel nonsense mutation suppressors patented by Novartis

Cellceutix designs novel agents for bacterial infections and cancer

Sumitomo Dainippon Pharma discloses new 5-HT4 receptor agonists

Roche discloses novel BTK inhibitors

Aegis Therapeutics seeks to out-license octreotide nasal spray

Glenmark's GBR-830 enters human trials for autoimmune diseases

Teva Pharmaceutical receives positive CHMP opinion for Seasonique

Japanese approval of Alecensa for ALK-positive NSCLC

Nivolumab, the first drug targeting PD-1 approved

Japanese approval for biosimilar infliximab

European approval for Arzerra in first-line treatment of CLL

Kitasato Daiichi Sankyo Vaccine obtains pertussis-diphtheria-tetanus-polio vaccine licenses

Deltyba approved in Japan for multidrug-resistant tuberculosis

Canagliflozin approved in Japan for type 2 diabetes

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...